We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01747551
Recruitment Status : Active, not recruiting
First Posted : December 11, 2012
Last Update Posted : May 10, 2016
Information provided by (Responsible Party):
Peter C. Enzinger, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2016
  Study Completion Date : No date given